Jie Tian

Dr. Jie Tian

Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, Jiangsu University School of Medicine, Zhenjiang 212013, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2022 in Cellular & Molecular Immunology
Verified
Journal Article
Open access
PDF file
FXFan Xiao
Fan Xiao
KRKe Rui
Ke Rui
XSXiaofei Shi
Xiaofei Shi
HWHaijing Wu
Haijing Wu
XCXiaoyan Cai
Xiaoyan Cai
LLLiwei Lu
Liwei Lu
B cells play a pivotal role in the pathogenesis of autoimmune diseases. Although previous studies have shown many genetic polymorphisms associated with B-cell activation in patients with various autoimmune disorders, progress in epigenetic research has revealed new mechanisms leading to B-cell hyperactivation. Epigenetic mechanisms, including those involving histone modifications, DNA methylation, and noncoding RNAs, regulate B-cell responses, and their dysregulation can contribute to the pathogenesis of autoimmune diseases. Patients with autoimmune diseases show epigenetic alterations that lead to the initiation and perpetuation of autoimmune inflammation. Moreover, many clinical and animal model studies have shown the promising potential of epigenetic therapies for patients. In this review, we present an up-to-date overview of epigenetic mechanisms with a focus on their roles in regulating functional B-cell subsets. Furthermore, we discuss epigenetic dysregulation in B cells and highlight its contribution to the development of autoimmune diseases. Based on clinical and preclinical evidence, we discuss novel epigenetic biomarkers and therapies for patients with autoimmune disorders.

23 May 2023 in Journal of Autoimmunity
Verified
Journal Article
Closed access
WHWei Huang
Wei Huang
KRKe Rui
Ke Rui
XWXiaomeng Wang
Xiaomeng Wang
NPNa Peng
Na Peng
WZWenhao Zhou
Wenhao Zhou
Jie TianJie Tian
Jie Tian

28 March 2023 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
KRKe Rui
Ke Rui
XTXiaoxuan Tang
Xiaoxuan Tang
ZSZiwei Shen
Ziwei Shen
CJChao Jiang
Chao Jiang
QZQiugang Zhu
Qiugang Zhu
YYYumin Yang
Yumin Yang
Although exosome therapy has been recognized as a promising strategy in the treatment of rheumatoid arthritis (RA), sustained modulation on RA specific pathogenesis and desirable protective effects for attenuating joint destruction still remain challenges. Here, silk fibroin hydrogel encapsulated with olfactory ecto-mesenchymal stem cell-derived exosomes (Exos@SFMA) was photo-crosslinked in situ to yield long-lasting therapeutic effect on modulating the immune microenvironment in RA. This in situ hydrogel system exhibited flexible mechanical properties and excellent biocompatibility for protecting tissue surfaces in joint. Moreover, the promising PD-L1 expression was identified on the exosomes, which potently suppressed Tfh cell polarization via inhibiting the PI3K/AKT pathway. Importantly, Exos@SFMA effectively relieved synovial inflammation and joint destruction by significantly reducing T follicular helper (Tfh) cell response and further suppressing the differentiation of germinal center (GC) B cells into plasma cells. Taken together, this exosome enhanced silk fibroin hydrogel provides an effective strategy for the treatment of RA and other autoimmune diseases.

1 April 2023 in Biomarker Research
Verified
Journal Article
Open access
PDF file
QYQingfang Yuan
Qingfang Yuan
NPNa Peng
Na Peng
FXFan Xiao
Fan Xiao
XSXiaofei Shi
Xiaofei Shi
BZBo Zhu
Bo Zhu
LLLiwei Lu
Liwei Lu
Interleukin-25 (IL-25), also known as IL-17E, is a cytokine belonging to the IL-17 family. IL-25 is abundantly expressed by Th2 cells and various kinds of epithelial cells. IL-25 is an alarm signal generated upon cell injury or tissue damage to activate immune cells through the interaction with IL-17RA and IL-17RB receptors. The binding of IL-25 to IL-17RA/IL-17RB complex not only initiates and maintains type 2 immunity but also regulates other immune cells (e.g., macrophages and mast cells) via various signaling pathways. It has been well-documented that IL-25 is critically involved in the development of allergic disorders (e.g., asthma). However, the roles of IL-25 in the pathogenesis of other diseases and the underlying mechanisms are still unclear. This review presents current evidence on the roles of IL-25 in cancers, allergic disorders, and autoimmune diseases. Moreover, we discuss the unanswered key questions underlying IL-25-mediated disease pathology, which will provide new insights into the targeted therapy of this cytokine in clinical treatment.

29 January 2025 in Biomarker Research
Verified
Journal Article
Open access
PDF file
XWXiaomeng Wang
Xiaomeng Wang
YHYue Hong
Yue Hong
JZJinmei Zou
Jinmei Zou
BZBo Zhu
Bo Zhu
CJChao Jiang
Chao Jiang
KRKe Rui
Ke Rui
As a member of the Activator Protein-1 (AP-1) transcription factor family, the Basic Leucine Zipper Transcription Factor (BATF) mediates multiple biological functions of immune cells through its involvement in protein interactions and binding to DNA. Recent studies have demonstrated that BATF not only plays pivotal roles in innate and adaptive immune responses but also acts as a crucial factor in the differentiation and function of various immune cells. Lines of evidence indicate that BATF is associated with the onset and progression of allergic diseases, graft-versus-host disease, tumors, and autoimmune diseases. This review summarizes the roles of BATF in the development and function of innate and adaptive immune cells, as well as its immunoregulatory effects in the development of autoimmune diseases, which may enhance the current understanding of the pathogenesis of autoimmune diseases and facilitate the development of new therapeutic strategies.

17 July 2025 in Autoimmunity Reviews
Verified
Journal Article
Closed access
YLYutong Liu
Yutong Liu
XJXueling Jiang
Xueling Jiang
SZSongnian Zhuang
Songnian Zhuang
LZLihua Zhu
Lihua Zhu
BZBo Zhu
Bo Zhu
Jie TianJie Tian
Jie Tian